| Thai Vinh Le, DC, MD | |
|
6900 N Pecos Rd, North Las Vegas, NV 89086-4400 | |
| (702) 791-9000 | |
| Not Available |
| Full Name | Thai Vinh Le |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 6900 N Pecos Rd, North Las Vegas, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740544493 | NPI | - | NPPES |
| 003163189A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | C156106 (California) | Primary |
| Entity Name | Athens Hospitalist Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295803013 PECOS PAC ID: 6709770167 Enrollment ID: O20040209000626 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new service line designed to provide a focused, market-driven approach to regulatory outsourcing services in the life sciences industry, with a primary emphasis on post-approval regulatory activities.
During a Thursday morning press call, Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid Services Administrator Donald Berwick unveiled the long-awaited federal rule on accountable care organizations.
A.P. Pharma, Inc., a specialty pharmaceutical company, today provided an update on its lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.
› Verified 5 days ago
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20060419000545 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new service line designed to provide a focused, market-driven approach to regulatory outsourcing services in the life sciences industry, with a primary emphasis on post-approval regulatory activities.
During a Thursday morning press call, Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid Services Administrator Donald Berwick unveiled the long-awaited federal rule on accountable care organizations.
A.P. Pharma, Inc., a specialty pharmaceutical company, today provided an update on its lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.
› Verified 5 days ago
| Entity Name | North Atlanta Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316959869 PECOS PAC ID: 0840291944 Enrollment ID: O20070116000197 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new service line designed to provide a focused, market-driven approach to regulatory outsourcing services in the life sciences industry, with a primary emphasis on post-approval regulatory activities.
During a Thursday morning press call, Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid Services Administrator Donald Berwick unveiled the long-awaited federal rule on accountable care organizations.
A.P. Pharma, Inc., a specialty pharmaceutical company, today provided an update on its lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.
› Verified 5 days ago
| Entity Name | Phoebe Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487899464 PECOS PAC ID: 8426112350 Enrollment ID: O20090121000583 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new service line designed to provide a focused, market-driven approach to regulatory outsourcing services in the life sciences industry, with a primary emphasis on post-approval regulatory activities.
During a Thursday morning press call, Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid Services Administrator Donald Berwick unveiled the long-awaited federal rule on accountable care organizations.
A.P. Pharma, Inc., a specialty pharmaceutical company, today provided an update on its lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.
› Verified 5 days ago
| Entity Name | Ctca Physicians Group Of Georgia, Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447520333 PECOS PAC ID: 4880841212 Enrollment ID: O20120820001117 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new service line designed to provide a focused, market-driven approach to regulatory outsourcing services in the life sciences industry, with a primary emphasis on post-approval regulatory activities.
During a Thursday morning press call, Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid Services Administrator Donald Berwick unveiled the long-awaited federal rule on accountable care organizations.
A.P. Pharma, Inc., a specialty pharmaceutical company, today provided an update on its lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thai Vinh Le, DC, MD 10158 Darrow Ct, Las Vegas, NV 89166-2511 Ph: (609) 705-0571 | Thai Vinh Le, DC, MD 6900 N Pecos Rd, North Las Vegas, NV 89086-4400 Ph: (702) 791-9000 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new service line designed to provide a focused, market-driven approach to regulatory outsourcing services in the life sciences industry, with a primary emphasis on post-approval regulatory activities.
During a Thursday morning press call, Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid Services Administrator Donald Berwick unveiled the long-awaited federal rule on accountable care organizations.
A.P. Pharma, Inc., a specialty pharmaceutical company, today provided an update on its lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.
› Verified 5 days ago
Dr. Audrey Marie Vasquez Veloso, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 | |
Darlito Serafica, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 | |
Dr. Lawrence R Smith, DC, M.D Hospitalist Medicare: Medicare Enrolled Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 | |
Kristi Lee Taylor, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 | |
Susil Sivaraman, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-682-5232 | |
Dr. Cleofemarie S Vergara, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 |